FDA Approved: METHYLPHENIDATE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for methylphenidate (Sandoz Inc) to update the product labeling under the NDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Narcolepsy

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

SUPPL AP for METHYLPHENIDATE (METHYLPHENIDATE)